174 related articles for article (PubMed ID: 33579876)
1. Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey.
Patacchini A; Cosci F
Int J Risk Saf Med; 2021; 32(3):229-242. PubMed ID: 33579876
[TBL] [Abstract][Full Text] [Related]
2. Characterizing post-SSRI sexual dysfunction and its impact on quality of life through an international online survey.
Studt A; Gannon M; Orzel J; Vaughan A; Pearlman AM
Int J Risk Saf Med; 2021; 32(4):321-329. PubMed ID: 34366299
[TBL] [Abstract][Full Text] [Related]
3. Post-SSRI Sexual Dysfunction: Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Response Relationship.
Ben-Sheetrit J; Aizenberg D; Csoka AB; Weizman A; Hermesh H
J Clin Psychopharmacol; 2015 Jun; 35(3):273-8. PubMed ID: 25815755
[TBL] [Abstract][Full Text] [Related]
4. Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors.
Peleg LC; Rabinovitch D; Lavie Y; Rabbie DM; Horowitz I; Fruchter E; Gruenwald I
Sex Med Rev; 2022 Jan; 10(1):91-98. PubMed ID: 34627736
[TBL] [Abstract][Full Text] [Related]
5. Post-SSRI Sexual Dysfunction: A Literature Review.
Bala A; Nguyen HMT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):29-34. PubMed ID: 28778697
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
7. The pathophysiology of Post SSRI Sexual Dysfunction - Lessons from a case study.
Klaas S; Siva JB; Bak M; Govers M; Schreiber R
Biomed Pharmacother; 2023 May; 161():114166. PubMed ID: 36898260
[TBL] [Abstract][Full Text] [Related]
8. Sexual Consequences of Post-SSRI Syndrome.
Reisman Y
Sex Med Rev; 2017 Oct; 5(4):429-433. PubMed ID: 28642048
[TBL] [Abstract][Full Text] [Related]
9. An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder.
Schwartz TL; Nasra GS; Ashton AK; Kang D; Kumaresan H; Chilton M; Bertone F
Ann Clin Psychiatry; 2007; 19(1):25-30. PubMed ID: 17453658
[TBL] [Abstract][Full Text] [Related]
10. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
[TBL] [Abstract][Full Text] [Related]
11. Persistent sexual dysfunction after SSRI withdrawal: a scoping review and presentation of 86 cases from the Netherlands.
Chinchilla Alfaro K; van Hunsel F; Ekhart C
Expert Opin Drug Saf; 2022 Apr; 21(4):553-561. PubMed ID: 34791958
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.
Kurose K; Hiratsuka K; Ishiwata K; Nishikawa J; Nonen S; Azuma J; Kato M; Wakeno M; Okugawa G; Kinoshita T; Kurosawa T; Hasegawa R; Saito Y
Psychiatry Res; 2012 Aug; 198(3):424-9. PubMed ID: 22445761
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.
Tarchi L; Merola GP; Baccaredda-Boy O; Arganini F; Cassioli E; Rossi E; Maggi M; Baldwin DS; Ricca V; Castellini G
Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1053-1067. PubMed ID: 37294623
[TBL] [Abstract][Full Text] [Related]
14. SSRI/SNRI -induced Hyponatremia: A Case Series of 26 Patients in a Single Institution from 2018 to 2020.
Zhao Z; Zhao F; Jin P; Hu X; Tian C; Liu D; Zhang Y
Psychiatr Q; 2023 Jun; 94(2):113-125. PubMed ID: 36913163
[TBL] [Abstract][Full Text] [Related]
15. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
Cosci F; Chouinard G; Chouinard VA; Fava GA
Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
[TBL] [Abstract][Full Text] [Related]
16. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
[TBL] [Abstract][Full Text] [Related]
17. Association between selective serotonin and serotonin-noradrenaline reuptake inhibitor therapy and hematuria.
Sarier M; Demir M; Emek M; Özgen A; Turgut H; Özdemir C
Nord J Psychiatry; 2023 Jan; 77(1):31-35. PubMed ID: 35243962
[TBL] [Abstract][Full Text] [Related]
18. A clinical review of antidepressants, their sexual side-effects, post-SSRI sexual dysfunction, and serotonin syndrome.
Marks S
Br J Nurs; 2023 Jul; 32(14):678-682. PubMed ID: 37495413
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.
Healy D; Bahrick A; Bak M; Barbato A; Calabrò RS; Chubak BM; Cosci F; Csoka AB; D'Avanzo B; Diviccaro S; Giatti S; Goldstein I; Graf H; Hellstrom WJG; Irwig MS; Jannini EA; Janssen PKC; Khera M; Kumar MT; Le Noury J; Lew-Starowicz M; Linden DEJ; Lüning C; Mangin D; Melcangi RC; Rodríguez OWMAAS; Panicker JN; Patacchini A; Pearlman AM; Pukall CF; Raj S; Reisman Y; Rubin RS; Schreiber R; Shipko S; Vašečková B; Waraich A
Int J Risk Saf Med; 2022; 33(1):65-76. PubMed ID: 34719438
[TBL] [Abstract][Full Text] [Related]
20. Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals.
Healy D; Le Noury J; Mangin D
Int J Risk Saf Med; 2019; 30(3):167-178. PubMed ID: 31450514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
